Current Perspectives in Therapeutic Myocardial Angiogenesis (Q35561306)

8 August 2017

1 reference

title

Current perspectives in therapeutic myocardial angiogenesis (English)

1 reference

8 August 2017

Current Perspectives in Therapeutic Myocardial Angiogenesis (English)

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.08061.X

cell- and tissue-based therapy

22 March 2024

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562668

Cardiology and cardiovascular medicine

22 March 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.08061.X

22 March 2024

2

Eugenio Stabile

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562668

22 March 2024

3

Eugenio Stabile

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562668

22 March 2024

author name string

Tim Kinnaird

1

1 reference

8 August 2017

Eugenio Stabile

2

1 reference

8 August 2017

Shmuel Fuchs

5

1 reference

8 August 2017

Stephen E. Epstein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562668

22 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14562668

22 March 2024

publication date

1 August 2003

1 reference

full work available at URL

8 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1600-6143.2003.08061.x

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.08061.X

Journal of Interventional Cardiology

22 March 2024

published in

1 reference

8 August 2017

16

1 reference

8 August 2017

4

1 reference

8 August 2017

289-297

1 reference

Molecular mechanisms of coronary collateral vessel growth

8 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

Effects of acidic fibroblast growth factor on normal and ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

Age-dependent impairment of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Mechanisms of angiogenesis and arteriogenesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Microvascular and collateral adaptation in swine hearts following progressive coronary artery stenosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Angiogenic therapy for the chronically ischemic lower limb in a rabbit model.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Isolation of putative progenitor endothelial cells for angiogenesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Angiogenesis in ischemic human myocardium: clinical results after 3 years

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Autologous bone-marrow stem-cell transplantation for myocardial regeneration

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Angiopoietin-1 protects the adult vasculature against plasma leakage.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Effect of diabetes mellitus on formation of coronary collateral vessels

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.08061.X

7 January 2021

Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis

4

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.08061.X

Basic fibroblast growth factor enhances myocardial collateral flow in a canine model

22 March 2024

11

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.08061.X

22 March 2024

Identifiers

1 reference

8 August 2017

1 reference